WEREWOLF THERAPEUTICS, INC. (HOWL)

Import this data to Google Sheets with:

=jivedata("HOWL","financials")

Full statements spill as a table. For one cell: =jivedata("HOWL","Revenue") or =jivedata("HOWL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

WEREWOLF THERAPEUTICS, INC.

HOWL • CIK 0001785530

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer	$19,943	$1,885	$0	$21,000
Operating Income (Loss)	$-40,503	$-73,594	$-60,677	$-31,257
Net Income (Loss) Attributable to Parent	$-37,368	$-70,515	$-60,822	$-34,613
Research and Development Expense	$41,776	$56,434	$44,830	$32,910
General and Administrative Expense	$18,670	$19,045	$15,847	$19,347
Operating Expenses	$60,446	$75,479	$60,677	$52,257
Investment Income, Interest	$7,416	$6,673	$3,108	$1,971
InterestExpenseNonoperating	—	$4,656	$5,274	$4,553
Gain (Loss) on Extinguishment of Debt	—	$-553	$0	$-3,354
Other Nonoperating Income (Expense)	$-1,142	$1,615	$2,021	$2,580
Nonoperating Income (Expense)	$3,135	$3,079	$-145	$-3,356
Weighted Average Number of Shares Outstanding, Basic	35,646,572	43,332,088	46,018,888	49,711,185
Weighted Average Number of Shares Outstanding, Diluted	35,646,572	43,859,664	46,810,252	50,502,549
Net Income (Loss) Available to Common Stockholders, Basic	—	$-70,515	$-60,822	$-56,265
Interest on Convertible Debt, Net of Tax	—	$493	$776	$975
Net Income (Loss) Available to Common Stockholders, Diluted	—	$-71,643	$-62,116	$-58,034
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities	—	527,576	791,364	1,582,728

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$134,343	$110,995	$57,050	$21,987
Prepaid Expense and Other Assets, Current	$2,677	$2,071	$1,536	$905
Property, Plant and Equipment, Net	$7,958	$6,322	$4,688	$1,263
Assets, Current	$138,370	$113,066	$58,586	$22,892
Restricted Cash, Noncurrent	$21,023	$1,220	$901	$0
Common Stock, Shares, Outstanding	39,107,048	44,827,159	48,596,817	48,599,066
Operating Lease, Right-of-Use Asset	$6,888	$6,001	$5,216	$0
Other Assets, Noncurrent	$594	$320	$5	$0
Assets	$174,833	$126,929	$69,396	$24,155
Operating Lease, Liability, Noncurrent	$10,992	$9,435	$7,684	$0
Notes Payable, Noncurrent	$32,656	$26,095	$0	$0
Derivative Liability, Noncurrent	—	$2,829	$759	$0
Liabilities	$63,459	$53,539	$44,591	$7,863
Accounts Payable, Current	$1,336	$3,035	$754	$1,939
Accrued Liabilities, Current	$8,860	$10,588	$5,407	$5,924
Operating Lease, Liability, Current	$1,608	$1,557	$1,751	$0
Notes Payable, Current	$6,667	$0	$28,236	$0
Liabilities, Current	$19,378	$15,180	$36,148	$7,863
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$4	$5	$5	$5
Additional Paid in Capital	$455,443	$487,973	$500,210	$501,559
Retained Earnings (Accumulated Deficit)	$-344,073	$-414,588	$-475,410	$-485,272
Stockholders' Equity Attributable to Parent	$111,374	$73,390	$24,805	$16,292
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-37,368	$-70,515	$-60,822	$-34,613
Net Cash Provided by (Used in) Operating Activities	$-32,612	$-56,188	$-60,292	$-30,148
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$25,048	$-43,362	$-54,264	$-56,504
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$155,577	$112,215	$57,951	$1,447
Share-based Payment Arrangement, Noncash Expense	$8,008	$8,826	$6,245	$3,794
Payments to Acquire Property, Plant, and Equipment	$769	$254	$0	$0
Depreciation	$1,764	$1,814	$1,634	$3,652
Net Cash Provided by (Used in) Investing Activities	$-769	$-254	$0	$416
Operating Lease, Right-of-Use Asset, Amortization Expense	$1,575	$887	$785	$711
Gain (Loss) on Extinguishment of Debt	—	$-553	$0	$-3,354
Derivative, Gain (Loss) on Derivative, Net	—	$1,621	$2,070	$2,587
Increase (Decrease) in Prepaid Expense and Other Assets	$-1,267	$-669	$-850	$-2,060
Proceeds from Issuance of Common Stock	$18,329	$23,576	$5,939	$5,592
Increase (Decrease) in Other Receivables	$-5,578	$-1,350	$0	$0
Proceeds from Issuance of Debt	$40,000	$30,000	$0	$0
Increase (Decrease) in Accounts Payable and Other Operating Liabilities	$-4,335	$3,455	$-7,498	$-3,448
Payments of Debt Issuance Costs	—	$673	$0	$0
Increase (Decrease) in Contract with Customer, Liability	$-6,320	$-1,340	$0	$0
Repayments of Secured Debt	—	$40,000	$0	$0
IncreaseDecreaseInOperatingLeaseLiability	$-2,084	$-1,608	$-1,557	$-3,990
Proceeds from Stock Plans	$93	$142	$89	$49
Proceeds from Stock Options Exercised	$7	$35	$0	$0
Net Cash Provided by (Used in) Financing Activities	$58,429	$13,080	$6,028	$-26,772
Interest Paid, Excluding Capitalized Interest, Operating Activities	$2,556	$3,358	$3,133	$2,909

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("HOWL","financials")

Full statements spill as a table. For one cell: =jivedata("HOWL","Revenue") or =jivedata("HOWL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.